Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Change in Acquisitions & Divestments (2019 - 2026)

Pliant Therapeutics has reported Change in Acquisitions & Divestments over the past 8 years, most recently at $60.7 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 27.33% to $60.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $315.1 million through Mar 2026, down 3.22% year-over-year, with the annual reading at $337.9 million for FY2025, 4.94% down from the prior year.
  • Change in Acquisitions & Divestments was $60.7 million for Q1 2026 at Pliant Therapeutics, down from $86.9 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $152.8 million in Q3 2023 and troughed at $33.8 million in Q3 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $83.5 million (2025), against an average of $81.7 million.
  • Year-over-year, Change in Acquisitions & Divestments plummeted 55.36% in 2022 and then surged 352.17% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $56.5 million in 2022, then surged by 58.36% to $89.5 million in 2023, then dropped by 18.76% to $72.7 million in 2024, then grew by 19.48% to $86.9 million in 2025, then tumbled by 30.11% to $60.7 million in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Change in Acquisitions & Divestments are $60.7 million (Q1 2026), $86.9 million (Q4 2025), and $80.3 million (Q3 2025).